摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[4-(methylthio)phenyl]-2-phenylethanone oxime

中文名称
——
中文别名
——
英文名称
1-[4-(methylthio)phenyl]-2-phenylethanone oxime
英文别名
1-(4-methylsulfanyl-phenyl)-2-phenyl-ethanone oxime;(NE)-N-[1-(4-methylsulfanylphenyl)-2-phenylethylidene]hydroxylamine
1-[4-(methylthio)phenyl]-2-phenylethanone oxime化学式
CAS
——
化学式
C15H15NOS
mdl
——
分子量
257.356
InChiKey
KKMUQBMQICDYRH-FOCLMDBBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    57.9
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    1-[4-(methylthio)phenyl]-2-phenylethanone oxime乙酸乙酯正丁基锂 作用下, 生成 5-methyl-3-(4-methylsulfanylphenyl)-4-phenyl-4H-1,2-oxazol-5-ol
    参考文献:
    名称:
    [EN] PHARMACEUTICAL COMPOUNDS THAT REGENERATE IN VIVO TECHNICAL FIELD OF THE INVENTION
    [FR] COMPOSES PHARMACEUTIQUES QUI SE REGENERENT IN VIVO
    摘要:
    公开号:
    WO2005054204A3
  • 作为产物:
    描述:
    2-phenyl-4'-(methylthio)acetophenone盐酸羟胺sodium acetate 作用下, 以 乙醇 为溶剂, 以87%的产率得到1-[4-(methylthio)phenyl]-2-phenylethanone oxime
    参考文献:
    名称:
    1,2-Diaryl(3-pyridyl)ethanone Oximes. Intermolecular Hydrogen Bonding Networks Revealed by X-ray Diffraction
    摘要:
    报告了一组 1-芳基-2-芳基(3-吡啶基)乙酮 1-5 和相应的酮肟 6-9 的合成。利用 1H-NMR 对肟 6、7 和 9 在溶液中的结构进行了研究,并利用 X 射线晶体学对其在固态下的结构进行了研究,从而提供了 H 键网络的证据。对于 6 来说,晶体堆积是由同分异构体分子间的肟--肟 H 键相互作用控制的,而对于 7 和 9 来说,则是由合作的肟--N(吡啶基)和 CH/π 相互作用控制的。
    DOI:
    10.3390/molecules13020301
点击查看最新优质反应信息

文献信息

  • O-acyloxime photoinitiators
    申请人:Ciba Specialty Chemicals Corporation
    公开号:US06596445B1
    公开(公告)日:2003-07-22
    Oximeester compounds of the formulae I, II, III and IV wherein R1 is phenyl, C1-C20alkyl or C2-C20alkyl optionally interrupted by —O—, C2-C20alkanoyl or benzoyl, or R1 is C2-C12alkoxycarbonyl or phenoxycarbonyl; R1′ is C2-C12alkoxycarbonyl, or R1′ is phenoxycarbonyl, or R1′ is —CONR10R11 or CN; R2 is C2-C12alkanoyl, C4-C6alkenoyl, benzoyl, C2-C6alkoxycarbonyl or phenoxycarbonyl; R3, R4, R5, R6 and R7 are hydrogen, halogen, C1-C12alkyl, cyclopentyl, cyclohexyl, phenyl, benzyl, benzoyl, C2-C12alkanoyl, C2-C12alkoxycarbonyl, phenoxycarbonyl or a group OR8, SR9, SOR9, SO2R9 or NR10R11; R4′, R5′ and R6′ are hydrogen, halogen, C1-C12alkyl, cyclopentyl, cyclohexyl, phenyl, benzyl, benzoyl, C2-C12-alkanoyl, C2-C12alkoxycarbonyl, phenoxycarbonyl, or are a group OR8, SR9, SOR9, SO2R9, NR10R11; provided that at least one of R3, R4, R5, R6, R7, R′4, R′5 and R′6 is OR8, SR9 or NR10R11; R8, R9, R10 and R11 are for example hydrogen, C1-C12alkyl, phenyl; are suitable as initiators for the photopolymerization of radically polymerizable compounds.
    化合物的公式I、II、III和IV,其中R1是苯基、C1-C20烷基或C2-C20烷基,可选地由—O—、C2-C20烷酰基或苯甲酰基中断,或者R1是C2-C12烷氧羰基或苯氧羰基;R1'是C2-C12烷氧羰基,或者R1'是苯氧羰基,或者R1'是—CONR10R11或CN;R2是C2-C12烷酰基、C4-C6烯酰基、苯甲酰基、C2-C6烷氧羰基或苯氧羰基;R3、R4、R5、R6和R7是氢、卤素、C1-C12烷基、环戊基、环己基、苯基、苄基、苯甲酰基、C2-C12烷酰基、C2-C12烷氧羰基、苯氧羰基或者一个OR8、SR9、SOR9、SO2R9或NR10R11基团;R4'、R5'和R6'是氢、卤素、C1-C12烷基、环戊基、环己基、苯基、苄基、苯甲酰基、C2-C12烷酰基、C2-C12烷氧羰基、苯氧羰基,或者是一个OR8、SR9、SOR9、SO2R9、NR10R11基团;但至少其中一个R3、R4、R5、R6、R7、R'4、R'5和R'6是OR8、SR9或NR10R11;R8、R9、R10和R11例如是氢、C1-C12烷基、苯基;适用作为引发剂用于自由基聚合可聚合化合物的光聚合。
  • CYCLOOXYGENASE-2 SELECTIVE AGENTS USEFUL AS IMAGING PROBES AND RELATED METHODS
    申请人:Toyokuni Tatsushi
    公开号:US20070286801A1
    公开(公告)日:2007-12-13
    This invention provides novel cyclooxygenase-2 selective agents that are particularly useful as imaging probes in non-invasive imaging techniques, such as PET and SPECT. Preferred cyclooxygenase-2 selective agents inhibit cyclooxygenase-2 activity with greater potency and specificity than conventional cyclooxygenase-2 inhibitors. Other aspects of the invention include pharmaceutical compositions including the cyclooxygenase-2 selective agents as well as methods for detecting and/or inhibiting cyclooxygenase-2. These methods are particularly useful for diagnosing and treating disorders, such as inflammation, which is characterized by elevated cyclooxygenase-2 levels.
    本发明提供了新颖的环氧合酶-2选择性药物,特别适用于非侵入性成像技术,如PET和SPECT的成像探针。优选的环氧合酶-2选择性药物比传统的环氧合酶-2抑制剂具有更强的效力和特异性。本发明的其他方面包括包括环氧合酶-2选择性药物的制药组合物以及检测和/或抑制环氧合酶-2的方法。这些方法特别适用于诊断和治疗疾病,如以升高的环氧合酶-2平为特征的炎症。
  • US6596445B1
    申请人:——
    公开号:US6596445B1
    公开(公告)日:2003-07-22
  • US7329401B2
    申请人:——
    公开号:US7329401B2
    公开(公告)日:2008-02-12
  • [EN] CYCLOOXYGENASE-2 SELECTIVE AGENTS USEFUL AS IMAGING PROBES AND RELATED METHODS<br/>[FR] AGENTS SELECTIFS EN FAVEUR DE LA CYCLOOXYGENASE-2 UTILES EN TANT QUE SONDES D'IMAGERIE ET PROCEDES CONNEXES
    申请人:UNIV CALIFORNIA
    公开号:WO2003089013A1
    公开(公告)日:2003-10-30
    This invention provides novel cyclooxygenase-2 selective agents that are particularly useful as imaging probes in non-invasive imaging techniques, such as PET and SPECT. Preferred cyclooxygenase-2 selective agents inhibit cyclooxygenase-2 activity with greater potency and specificity than conventional cyclooxygenase-2 inhibitors. Other aspects of the invention include pharmaceutical compositions including the cyclooxygenase-2 selective agents as well as methods for detecting and/or inhibiting cyclooxygenase-2. These methods are particularly useful for diagnosing and treating disorders, such as inflammation, which is characterized by elevated cyclooxygenase-2 levels.
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S,5R,5''R)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (4R,5S)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 黄子囊素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-白藜芦醇3-O-beta-D-葡糖苷酸 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1-(3-甲基-2-萘基)-2-(2-萘基)乙烯 顺式-1,2-双(三甲基硅氧基)-1,2-双(4-溴苯基)环丙烷 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 非洲李(PRUNUSAFRICANA)树皮提取物 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀杂质7 阿托伐他汀杂质5 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 锌(II)(苯甲醛)(四苯基卟啉) 银松素 铜酸盐(5-),[m-[2-[2-[1-[4-[2-[4-[[4-[[4-[2-[4-[4-[2-[2-(羧基-kO)苯基]二氮烯基-kN1]-4,5-二氢-3-甲基-5-(羰基-kO)-1H-吡唑-1-基]-2-硫代苯基]乙烯基]-3-硫代苯基]氨基]-6-(苯基氨基)-1,3,5-三嗪-2-基]氨基]-2-硫代苯基]乙烯基]-3-硫代 铒(III) 离子载体 I 铀,二(二苯基甲酮)四碘- 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯